Literature DB >> 8494713

Multivariate analysis of prognostic factors in patients with non HIV-related primary cerebral lymphoma. A proposal for a prognostic scoring.

J Y Blay1, C Lasset, C Carrie, F Chauvin, B Coiffier, C Gisselbrecht, M Clavel, P Rebattu, M Brunat-Mentigny, T Philip.   

Abstract

Between 1982 and 1991, 41 patients were treated for non HIV related primary cerebral lymphoma (PCL) in our institute. The purpose of this study was to perform a multivariate analysis of prognostic factors for survival in these patients. The presence of a CSF protein level over 0.6 g l-1 at diagnosis was found to be the most significant unfavourable prognostic factor in univariate analysis and had not previously been reported. Among the five significant prognostic factors at diagnosis, (age over 60 years, performance status--ECOG scale--over 2, memory dysfunction, non hemispheric tumour site, CSF protein level over 0.6 g l-1 at the diagnosis), three independent factors were identified in multivariate analysis: (1) CSF protein level (P = 0.007; RR = 4.7); (2) PS > 2 (P = 0.04, RR = 2.65); (3) age over 60 (P = 0.08; RR = 2.43). Using the regression coefficient of these three parameters, we determined a prognostic index which allowed us to distinguish three risk groups whose theoretical median survival is 4, 20 and 54, months respectively in patients with non HIV related PCL. These results indicate that PCL is an heterogeneous disease in terms of the prognostic in which three subgroups with discriminant survival can be identified.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8494713      PMCID: PMC1968460          DOI: 10.1038/bjc.1993.209

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  26 in total

Review 1.  Prognostic factors for survival in patients with recurrent or metastatic renal cell carcinoma.

Authors:  P J Elson; R S Witte; D L Trump
Journal:  Cancer Res       Date:  1988-12-15       Impact factor: 12.701

2.  Prognostic factors in the diagnosis and treatment of primary central nervous system lymphoma.

Authors:  I F Pollack; L D Lunsford; J C Flickinger; H L Dameshek
Journal:  Cancer       Date:  1989-03-01       Impact factor: 6.860

3.  Primary malignant lymphoma of the central nervous system.

Authors:  C R Freeman; C Shustik; M L Brisson; K Meagher-Villemure; I Dylewski
Journal:  Cancer       Date:  1986-09-01       Impact factor: 6.860

Review 4.  Primary lymphoma of the central nervous system. Computerized tomography scan characteristics and treatment results for 12 cases.

Authors:  N P Mendenhall; T L Thar; O F Agee; B Harty-Golder; W E Ballinger; R R Million
Journal:  Cancer       Date:  1983-12-01       Impact factor: 6.860

5.  Primary non-Hodgkin's lymphoma of the brain. A review.

Authors:  R Woodman; K Shin; G Pineo
Journal:  Medicine (Baltimore)       Date:  1985-11       Impact factor: 1.889

6.  Increasing incidence of primary brain lymphoma in the US.

Authors:  N L Eby; S Grufferman; C M Flannelly; S C Schold; F S Vogel; P C Burger
Journal:  Cancer       Date:  1988-12-01       Impact factor: 6.860

Review 7.  Primary central nervous system lymphoma.

Authors:  F H Hochberg; D C Miller
Journal:  J Neurosurg       Date:  1988-06       Impact factor: 5.115

8.  Primary lymphomas of the central nervous system: patterns of failure and factors that influence survival.

Authors:  J S Loeffler; T J Ervin; P Mauch; A Skarin; H J Weinstein; G Canellos; J R Cassady
Journal:  J Clin Oncol       Date:  1985-04       Impact factor: 44.544

9.  Primary malignant lymphoma of the central nervous system. Results of treatment of 11 cases and review of the literature.

Authors:  K Murray; L Kun; J Cox
Journal:  J Neurosurg       Date:  1986-11       Impact factor: 5.115

10.  Developments in the diagnosis and treatment of primary CNS lymphoma. A prospective series.

Authors:  E A Neuwelt; E P Frenkel; M K Gumerlock; R Braziel; B Dana; S A Hill
Journal:  Cancer       Date:  1986-10-15       Impact factor: 6.860

View more
  7 in total

Review 1.  Primary central nervous system lymphoma.

Authors:  W S Velasquez
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

2.  Clinical importance of Bcl-6-positive non-deep-site involvement in non-HIV-related primary central nervous system diffuse large B-cell lymphoma.

Authors:  Moo-Kon Song; Joo-Seop Chung; Young-Don Joo; Sang-Min Lee; Sung-Yong Oh; Dong-Hoon Shin; Eun-Young Yun; Seung-Geun Kim; Young-Mi Seol; Ho-Jin Shin; Young-Jin Choi; Goon-Jae Cho
Journal:  J Neurooncol       Date:  2011-03-06       Impact factor: 4.130

3.  Results of primary central nervous system lymphoma treated by radiation and chemotherapy: retrospective analysis of twelve institutions in the Tokai District of Japan, 1995-1999.

Authors:  Toshiki Kawamura; Tsuneo Ishiguchi; Yuta Shibamoto; Hiroyuki Ogino; Shunichi Ishihara; Tetsuya Yamada; Kazuhiro Katada; Kazunori Suzuki; Hiromasa Suzuki; Mikio Mimura
Journal:  Radiat Med       Date:  2006-01

4.  Primary brain lymphomas in patients with a prior or concomitant malignancy.

Authors:  M Reni; A J Ferreri; M C Zoldan; E Villa
Journal:  J Neurooncol       Date:  1997-04       Impact factor: 4.130

Review 5.  Statistical aspects of prognostic factor studies in oncology.

Authors:  R Simon; D G Altman
Journal:  Br J Cancer       Date:  1994-06       Impact factor: 7.640

6.  Risk Prediction for Early Mortality in Patients with Newly Diagnosed Primary CNS Lymphoma.

Authors:  Chia-Hsin Lin; Ching-Fen Yang; Huai-Che Yang; Li-Yu Fay; Chiu-Mei Yeh; Ai-Seon Kuan; Hao-Yuan Wang; Jyh-Pyng Gau; Liang-Tsai Hsiao; Tzeon-Jye Chiou; Po-Min Chen; Yao-Chung Liu; Po-Shen Ko; Jin-Hwang Liu; Chia-Jen Liu
Journal:  J Cancer       Date:  2019-07-05       Impact factor: 4.207

7.  R-MPV followed by high-dose chemotherapy with thiotepa-based and autologous stem cell transplantation for newly diagnosed primary central nervous system lymphoma: a single-center experience.

Authors:  Ji Yun Lee; Jin Ho Paik; Koung Jin Suh; Ji-Won Kim; Se Hyun Kim; Jin Won Kim; Yu Jung Kim; Keun-Wook Lee; Jee Hyun Kim; Soo-Mee Bang; Jong-Seok Lee; Jeong-Ok Lee
Journal:  Blood Res       Date:  2021-12-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.